Intrauterine Growth Retardation
16
1
1
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
19%
3 trials in Phase 3/4
17%
2 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (16)
EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction
Exploration of Allograft Humoral Rejection in Chronic Histiocytic Intervillositis
The Effect of Neonatal Feeding Modalities on Splanchnic Oxygenation
Impact of Pre-pregnancy Micronutrient Supplementation on Maternal and Child Outcomes
Transplacental Aspirin Therapy for Early Onset Fetal Growth Restriction
The Possible Effect Of Amniotic Fluid pH On Neonatal Morbidities In Maternal Inflammation/Infection Associated Pregnancies
Sildenafil in Sever Intrauterine Growth Retardation
A Modernized Approach to Prenatal Care in Low Risk Women
Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.
Fish Oil Trials in Pregnancy for the Prevention of Pregnancy Complications ('FOTIP')
MorbiMortality Amelioration in Preeclamptic Primiparas Study. MoMA Pre Prim Study
Randomized Clinical Trial: Expectant Management vs Laser Treatment of Monochorionic Twins With Severe Selective Intrauterine Growth Retardation and Absent or Reverse Diastolic Flow in the Umbilical Artery
Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
Effect of Prenatal Nutritional Supplementation on Birth Outcome in Hounde District, Burkina Faso
Severe Intrauterine Growth Retardation: Developmental Newborn Intensive Care Unit (NICU) Care
Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation